News Archive

A bipartisan group of Representatives has introduced the Medicare Patient Access and Practice Stabilization Act, a crucial bill that ASBrS strongly supports.

The American College of Surgeons and the American Society of Breast Surgeons cosponsor an annual scholarship to subsidize attendance and participation in the Executive Leadership Program in Health Policy and Management at Brandeis University.

The American Society of Breast Surgeons (ASBrS) and Society of Breast Imaging (SBI) are developing evidence-informed, clinical consensus guidelines for the management of four benign breast disease entities. ASBrS and SBI are publishing these guidelines to provide trusted, actionable decision support to clinicians who manage the treatment of benign breast disease. The guidelines presented here for public comment represent Atypical Lobular Hyperplasia (ALH) and Lobular carcinoma in situ (LCIS) and Atypical Ductal Hyperplasia (ADH) and Flat epithelial atypia (FEA).

Primary results of the INSEMA (Intergroup-Sentinel-Mamma) trial were presented at the 2024 San Antonio Breast Cancer Symposium and simultaneously published online in the NEJM on December 12, 2024. The authors concluded that axillary sentinel lymph node surgery can be safely omitted in patients with clinically node-negative early breast cancer undergoing upfront breast-conserving surgery and whole breast radiation (breast-conserving therapy).